RxDoctor Payments Data

Jennifer Burke

Family · Englewood, CONPI 1356547392

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 506 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 26.2% of the total. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,495in general payments, 2019–2025

Across 506 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Incyte Corporation$1K
  • Johnson & Johnson$1K
  • Sun Pharmaceutical Industries Inc.$674
  • Novartis$416
  • Galderma Laboratories, L.p.$392
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$9,10596%
  • Education$3904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,495 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$125,998
Medicare patients
445
Services billed
3,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab14$54,652
Clobetasol Propionate45$1,331
Ciclopirox29$981
Ketoconazole66$918
Fluorouracil14$864
Spironolactone24$558
Clindamycin Phosphate11$508
Triamcinolone Acetonide36$433
Doxycycline Hyclate26$387
ValacyclovirValacyclovir Hcl13$253
Mupirocin21$148
Hydroxychloroquine Sulfate12$90

Paid to pharmacies, not to this prescriber.

Other family in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →